GlassScriptPhysician profile
Moira Stanley
NPI 1902182819
$9,383.32
in general payments reported to CMS, 2019-2025
11 companies · $6,955 in 2025
The $6,955 reported for 2025 was more than what 99% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.91 · 2023: $1,100 · 2024: $1,313 · 2025: $6,955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,491 · Food and Beverage: $2,937 · Travel and Lodging: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,490.50 |
| Food and Beverage | $2,936.94 |
| Travel and Lodging | $940.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $5,678.61 | 2025 | Micromatrix, Cytal, Integra |
| W. L. Gore & Associates, INC. | $1,828.64 | 2024-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Enform Intraperitoneal Biomaterial |
| Intuitive Surgical, INC. | $950.48 | 2023-2024 | Da Vinci Surgical System |
| Dilon Technologies, INC. | $479.14 | 2024 | Hemoblast Bellows |
| Baxter Healthcare | $145.63 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $121.20 | 2025 | |
| Davol INC. | $86.62 | 2025 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $30.66 | 2023-2025 | Gattex |
| Smith+Nephew, INC. | $25.55 | 2024 | Renasys Go V2 Home |
| Merck Sharp & Dohme LLC | $21.88 | 2024 | Bridion |
| Ibsa Pharma INC. | $14.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moira Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.